Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#1957 most reported symptom for this vaccine
Increased viscosity of upper respiratory secretion has been reported 4 times in association with Vaccine Not Specified vaccination in VAERS. This represents 0.0% of all 29,669 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 1 involved hospitalization (25.0%).
Increased viscosity of upper respiratory secretion is the #1957 most frequently reported symptom for Vaccine Not Specified out of 2482 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 4 reports of Increased viscosity of upper respiratory secretion after Vaccine Not Specified vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.